vs
Side-by-side financial comparison of Agilent Technologies (A) and AMN HEALTHCARE SERVICES INC (AMN). Click either name above to swap in a different company.
Agilent Technologies is the larger business by last-quarter revenue ($1.8B vs $1.4B, roughly 1.3× AMN HEALTHCARE SERVICES INC). Agilent Technologies runs the higher net margin — 17.0% vs 4.5%, a 12.5% gap on every dollar of revenue. On growth, AMN HEALTHCARE SERVICES INC posted the faster year-over-year revenue change (100.0% vs 7.0%). Over the past eight quarters, AMN HEALTHCARE SERVICES INC's revenue compounded faster (36.4% CAGR vs 6.9%).
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emissi...
AMN Healthcare Services Inc. is a leading US healthcare sector workforce solutions and staffing provider. It offers temporary and permanent placement for nurses, physicians, allied health and other clinical/non-clinical staff, plus workforce management tools and consulting for hospitals, clinics and other medical facilities.
A vs AMN — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.8B | $1.4B |
| Net Profit | $305.0M | $62.2M |
| Gross Margin | 52.6% | 26.8% |
| Operating Margin | 19.6% | 8.5% |
| Net Margin | 17.0% | 4.5% |
| Revenue YoY | 7.0% | 100.0% |
| Net Profit YoY | -4.1% | — |
| EPS (diluted) | $1.07 | $1.59 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.8B | $1.4B | ||
| Q4 25 | $1.9B | $748.2M | ||
| Q3 25 | $1.7B | $634.5M | ||
| Q2 25 | $1.7B | $658.2M | ||
| Q1 25 | $1.7B | $689.5M | ||
| Q4 24 | $1.7B | $734.7M | ||
| Q3 24 | $1.6B | $687.5M | ||
| Q2 24 | $1.6B | $740.7M |
| Q1 26 | $305.0M | $62.2M | ||
| Q4 25 | $434.0M | $-7.7M | ||
| Q3 25 | $336.0M | $29.3M | ||
| Q2 25 | $215.0M | $-116.2M | ||
| Q1 25 | $318.0M | $-1.1M | ||
| Q4 24 | $351.0M | $-187.5M | ||
| Q3 24 | $282.0M | $7.0M | ||
| Q2 24 | $308.0M | $16.2M |
| Q1 26 | 52.6% | 26.8% | ||
| Q4 25 | 53.2% | 26.1% | ||
| Q3 25 | 51.1% | 29.1% | ||
| Q2 25 | 51.9% | 29.8% | ||
| Q1 25 | 53.5% | 28.7% | ||
| Q4 24 | 53.9% | 29.8% | ||
| Q3 24 | 54.2% | 31.0% | ||
| Q2 24 | 54.4% | 31.0% |
| Q1 26 | 19.6% | 8.5% | ||
| Q4 25 | 23.8% | 1.1% | ||
| Q3 25 | 20.7% | 7.5% | ||
| Q2 25 | 18.0% | -18.8% | ||
| Q1 25 | 22.4% | 1.8% | ||
| Q4 24 | 24.0% | -27.6% | ||
| Q3 24 | 21.1% | 3.2% | ||
| Q2 24 | 23.1% | 5.1% |
| Q1 26 | 17.0% | 4.5% | ||
| Q4 25 | 23.3% | -1.0% | ||
| Q3 25 | 19.3% | 4.6% | ||
| Q2 25 | 12.9% | -17.7% | ||
| Q1 25 | 18.9% | -0.2% | ||
| Q4 24 | 20.6% | -25.5% | ||
| Q3 24 | 17.9% | 1.0% | ||
| Q2 24 | 19.6% | 2.2% |
| Q1 26 | $1.07 | $1.59 | ||
| Q4 25 | $1.53 | $-0.19 | ||
| Q3 25 | $1.18 | $0.76 | ||
| Q2 25 | $0.75 | $-3.02 | ||
| Q1 25 | $1.11 | $-0.03 | ||
| Q4 24 | $1.23 | $-4.90 | ||
| Q3 24 | $0.97 | $0.18 | ||
| Q2 24 | $1.05 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.8B | $560.7M |
| Total DebtLower is stronger | $3.0B | — |
| Stockholders' EquityBook value | $6.9B | — |
| Total Assets | $12.8B | $2.6B |
| Debt / EquityLower = less leverage | 0.44× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.8B | $560.7M | ||
| Q4 25 | $1.8B | $34.0M | ||
| Q3 25 | $1.5B | $52.6M | ||
| Q2 25 | $1.5B | $41.5M | ||
| Q1 25 | $1.5B | $55.8M | ||
| Q4 24 | $1.3B | $10.6M | ||
| Q3 24 | $1.8B | $30.6M | ||
| Q2 24 | $1.7B | $48.0M |
| Q1 26 | $3.0B | — | ||
| Q4 25 | $3.0B | $767.1M | ||
| Q3 25 | $3.4B | — | ||
| Q2 25 | $3.3B | — | ||
| Q1 25 | $3.3B | — | ||
| Q4 24 | $3.3B | $1.1B | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $2.1B | — |
| Q1 26 | $6.9B | — | ||
| Q4 25 | $6.7B | $642.1M | ||
| Q3 25 | $6.4B | $644.4M | ||
| Q2 25 | $6.1B | $607.6M | ||
| Q1 25 | $6.0B | $715.1M | ||
| Q4 24 | $5.9B | $706.6M | ||
| Q3 24 | $5.9B | $890.7M | ||
| Q2 24 | $6.2B | $876.9M |
| Q1 26 | $12.8B | $2.6B | ||
| Q4 25 | $12.7B | $2.1B | ||
| Q3 25 | $12.2B | $2.1B | ||
| Q2 25 | $12.2B | $2.2B | ||
| Q1 25 | $11.9B | $2.4B | ||
| Q4 24 | $11.8B | $2.4B | ||
| Q3 24 | $11.0B | $2.7B | ||
| Q2 24 | $10.9B | $2.8B |
| Q1 26 | 0.44× | — | ||
| Q4 25 | 0.45× | 1.19× | ||
| Q3 25 | 0.53× | — | ||
| Q2 25 | 0.55× | — | ||
| Q1 25 | 0.56× | — | ||
| Q4 24 | 0.57× | 1.49× | ||
| Q3 24 | 0.36× | — | ||
| Q2 24 | 0.34× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $268.0M | $562.5M |
| Free Cash FlowOCF − Capex | $175.0M | — |
| FCF MarginFCF / Revenue | 9.7% | — |
| Capex IntensityCapex / Revenue | 5.2% | — |
| Cash ConversionOCF / Net Profit | 0.88× | 9.04× |
| TTM Free Cash FlowTrailing 4 quarters | $993.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $268.0M | $562.5M | ||
| Q4 25 | $545.0M | $75.6M | ||
| Q3 25 | $362.0M | $22.7M | ||
| Q2 25 | $221.0M | $78.5M | ||
| Q1 25 | $431.0M | $92.7M | ||
| Q4 24 | $481.0M | $72.8M | ||
| Q3 24 | $452.0M | $66.7M | ||
| Q2 24 | $333.0M | $99.5M |
| Q1 26 | $175.0M | — | ||
| Q4 25 | $452.0M | $67.6M | ||
| Q3 25 | $259.0M | $14.8M | ||
| Q2 25 | $107.0M | $68.7M | ||
| Q1 25 | $334.0M | $82.7M | ||
| Q4 24 | $388.0M | $56.6M | ||
| Q3 24 | $360.0M | $47.4M | ||
| Q2 24 | $230.0M | $72.2M |
| Q1 26 | 9.7% | — | ||
| Q4 25 | 24.3% | 9.0% | ||
| Q3 25 | 14.9% | 2.3% | ||
| Q2 25 | 6.4% | 10.4% | ||
| Q1 25 | 19.9% | 12.0% | ||
| Q4 24 | 22.8% | 7.7% | ||
| Q3 24 | 22.8% | 6.9% | ||
| Q2 24 | 14.6% | 9.8% |
| Q1 26 | 5.2% | — | ||
| Q4 25 | 5.0% | 1.1% | ||
| Q3 25 | 5.9% | 1.2% | ||
| Q2 25 | 6.8% | 1.5% | ||
| Q1 25 | 5.8% | 1.4% | ||
| Q4 24 | 5.5% | 2.2% | ||
| Q3 24 | 5.8% | 2.8% | ||
| Q2 24 | 6.5% | 3.7% |
| Q1 26 | 0.88× | 9.04× | ||
| Q4 25 | 1.26× | — | ||
| Q3 25 | 1.08× | 0.77× | ||
| Q2 25 | 1.03× | — | ||
| Q1 25 | 1.36× | — | ||
| Q4 24 | 1.37× | — | ||
| Q3 24 | 1.60× | 9.54× | ||
| Q2 24 | 1.08× | 6.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
AMN
Segment breakdown not available.
